Alzheimer's disease represents a major healthcare crisis. An estimated 5.7 million Americans suffer from this disease. As the most common type of dementia, Alzheimer's disease is a neurodegenerative disease characterized by the presence of beta-amyloid and tau proteins within brain and nerve cells. This condition disproportionately impacts menopausal women to the tune of 3.2 million diagnosed with this condition. A few unmodifiable risk factors have been identified, such as aging, family history, and genetics, but we are only beginning to understand the link between different hormones and Alzheimer's, particularly in menopausal women.
Epidemiological studies highlight metabolic abnormalities as an important contributor to Alzheimer's disease. Thus, early and accurate identification of metabolic risk factors, such as insulin resistance and hormonal imbalances, may help to delay or decrease progression of Alzheimer's disease.
Doctor Trindade will discuss her unique approach, which incorporates functional medicine principles, and offer clinical pearls to address Alzheimer's disease, particularly in women. This webinar will focus on applying and interpreting treatable metabolic and hormonal abnormalities, shown in research to be contributing risk factors for the development and progression of Alzheimer's disease.
- Describe the contribution of insulin resistance and hormonal imbalance in the development and progression of Alzheimer's disease
- Review a treatment approach in patients with increased risk, or who already have, Alzheimer disease
Filomena Trindade, MD
Doctor Filomena Trindade is a teacher, author, and international sought after lecturer in functional medicine. She is faculty at the fellowship/master's program in Metabolic Medicine at Metabolic Medical Institute (MMI). In addition she is also faculty at the Institute for Functional Medicine (IFM).
After obtaining her BA degree in Biology she went on to finish a masters in Public Health in the area of environmental health and epidemiology before starting medical school. She graduated first in her class in family practice from the University of California Davis School of Medicine and did her residency training in family practice at the U.C. San Francisco/Santa Rosa Program.
She has been in clinical practice for over 22 years. Before starting her own private practice in 2004 in functional medicine, she was the medical director of a non-profit organization that catered to the underserved.
Her work has been published in Townsend Letter, Guide to Anti-Aging & Regenerative Medicine, Saúde (SAUDEE) Actual (AKTUAL), and the Border Health Journal. She is currently very active in developing teaching programs in Functional Medicine in the USA, Latin America and Europe. Keep up with her activities at www.drtrindade.com.